Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized trial of cisplatin + docetaxel versus cisplatin + vinorelbine as first-line treatment for advanced non-small cell lung cancer
2006-002934-40Phase 2Active
- Sponsor
- GOIM
- Start
- Jul 2007
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in non-small cell lung cancer (NSCLC) comparing Cisplatin + docetaxel with Cisplatin + vinorelbine (2 arms). Primary endpoints: Antitumor activity and Safety. Started Jul 2007; status: active.
02
Drugs
cisplatindocetaxelvinorelbine
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on 2006-002934-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-002934-40.